Regulating the price of prescription drugs in Canada : compulsory licensing, product selection, and government reimbursement programmes / by Paul K. Gorecki.: EC24-11/8-1981E-PDF
"The major findings of the study can be summarized as follows: prices have fallen, often substantially, at the level of the manufacturer for those drugs subject to licensee competition. These price reductions have been passed on to the consumer in the hospital market and, in varying degrees, in the provincial retail drug markets. It is not uncommon for expenditure on a particular licensed drug to be reduced by 50 percent from what it would have been without compulsory licensing and associated policy measures. Nevertheless further gains, often of considerable magnitude, can be achieved in virtually all markets"--Summary, p. xii.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.864450&sl=0
| Department/Agency | Economic Council of Canada. |
|---|---|
| Title | Regulating the price of prescription drugs in Canada : compulsory licensing, product selection, and government reimbursement programmes / by Paul K. Gorecki. |
| Series title | Technical report - Economic Council of Canada, 0225-8013 ; no. 8 |
| Publication type | Series - View Master Record |
| Language | [English] |
| Format | Electronic |
| Electronic document | |
| Note(s) | "May 1981." Digitized edition from print [produced by the Publishing and Depository Services Directorate]. Includes bibliographic references. Includes abstract in French. |
| Publishing information | Ottawa : Economic Council of Canada, 1981. |
| Author / Contributor | Gorecki, Paul K., 1948- |
| Description | xiii, 300 p. : figures, charts. |
| Catalogue number |
|
| Subject terms | Prescription drugs Price regulation |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: